End-of-day quote
Shenzhen S.E.
03:30:00 30/04/2024 am IST
|
5-day change
|
1st Jan Change
|
113.1
CNY
|
-1.20%
|
|
+2.41%
|
-22.46%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
90,455
|
1,81,683
|
1,09,841
|
66,954
|
58,638
|
45,470
|
-
|
-
|
Enterprise Value (EV)
1 |
90,455
|
1,81,683
|
1,09,841
|
66,954
|
58,638
|
45,470
|
45,470
|
45,470
|
P/E ratio
|
43.5
x
|
60.2
x
|
29.6
x
|
16.4
x
|
13.2
x
|
8.77
x
|
7.73
x
|
7.17
x
|
Yield
|
0.22%
|
0.18%
|
0.29%
|
0.6%
|
3.09%
|
2.53%
|
2.37%
|
3.25%
|
Capitalization / Revenue
|
12.3
x
|
21.2
x
|
10.2
x
|
5.3
x
|
4.03
x
|
2.75
x
|
2.44
x
|
2.22
x
|
EV / Revenue
|
12.3
x
|
21.2
x
|
10.2
x
|
5.3
x
|
4.03
x
|
2.75
x
|
2.44
x
|
2.22
x
|
EV / EBITDA
|
29.9
x
|
44.2
x
|
22
x
|
12.5
x
|
9.6
x
|
6.96
x
|
5.68
x
|
5.45
x
|
EV / FCF
|
-
|
1,28,45,51,251
x
|
9,93,44,922
x
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
0%
|
0%
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
11.2
x
|
16.6
x
|
7.54
x
|
3.73
x
|
2.67
x
|
1.72
x
|
1.43
x
|
1.23
x
|
Nbr of stocks (in thousands)
|
4,04,720
|
4,04,720
|
4,04,720
|
4,02,247
|
4,02,182
|
4,02,172
|
-
|
-
|
Reference price
2 |
223.5
|
448.9
|
271.4
|
166.4
|
145.8
|
113.1
|
113.1
|
113.1
|
Announcement Date
|
26/03/20
|
11/03/21
|
16/03/22
|
29/03/23
|
19/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
7,374
|
8,577
|
10,747
|
12,627
|
14,566
|
16,542
|
18,633
|
20,475
|
EBITDA
1 |
3,024
|
4,115
|
4,999
|
5,369
|
6,111
|
6,534
|
8,005
|
8,342
|
EBIT
1 |
2,876
|
3,936
|
4,715
|
4,968
|
5,588
|
6,541
|
7,408
|
7,969
|
Operating Margin
|
39.01%
|
45.89%
|
43.88%
|
39.34%
|
38.36%
|
39.54%
|
39.76%
|
38.92%
|
Earnings before Tax (EBT)
1 |
2,820
|
3,913
|
4,617
|
4,924
|
5,510
|
6,466
|
7,336
|
7,899
|
Net income
1 |
1,775
|
3,047
|
3,757
|
4,140
|
4,532
|
5,207
|
5,884
|
6,361
|
Net margin
|
24.07%
|
35.52%
|
34.96%
|
32.79%
|
31.12%
|
31.48%
|
31.58%
|
31.07%
|
EPS
2 |
5.135
|
7.460
|
9.170
|
10.16
|
11.06
|
12.90
|
14.62
|
15.77
|
Free Cash Flow
|
-
|
141.4
|
1,106
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
1.65%
|
10.29%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
3.44%
|
22.12%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
4.64%
|
29.43%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.5000
|
0.8000
|
0.8000
|
1.000
|
4.500
|
2.857
|
2.675
|
3.670
|
Announcement Date
|
26/03/20
|
11/03/21
|
16/03/22
|
29/03/23
|
19/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
3,884
|
3,177
|
3,899
|
5,191
|
4,467
|
3,546
|
4,328
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
2.200
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19/03/24
|
19/04/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
141
|
1,106
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
28.5%
|
31.2%
|
29.5%
|
25.7%
|
22.6%
|
19.5%
|
18.5%
|
17.2%
|
ROA (Net income/ Total Assets)
|
16%
|
20.6%
|
19.1%
|
17.1%
|
-
|
15.4%
|
15%
|
14.8%
|
Assets
1 |
11,068
|
14,783
|
19,680
|
24,272
|
-
|
33,923
|
39,224
|
42,886
|
Book Value Per Share
2 |
20.00
|
27.00
|
36.00
|
44.60
|
54.60
|
65.80
|
78.90
|
91.90
|
Cash Flow per Share
2 |
4.780
|
2.750
|
8.130
|
6.980
|
12.60
|
11.30
|
15.40
|
15.10
|
Capex
1 |
840
|
970
|
2,225
|
2,088
|
2,089
|
1,167
|
1,813
|
1,536
|
Capex / Sales
|
11.39%
|
11.3%
|
20.7%
|
16.54%
|
14.34%
|
7.05%
|
9.73%
|
7.5%
|
Announcement Date
|
26/03/20
|
11/03/21
|
16/03/22
|
29/03/23
|
19/03/24
|
-
|
-
|
-
|
Last Close Price
113.1
CNY Average target price
195.3
CNY Spread / Average Target +72.78% Consensus |
1st Jan change
|
Capi.
|
---|
| -22.46% | 6.28B | | +33.25% | 704B | | +28.59% | 577B | | -3.55% | 348B | | +18.16% | 327B | | +4.36% | 288B | | +14.81% | 234B | | +4.93% | 198B | | -9.78% | 194B | | -3.69% | 147B |
Other Pharmaceuticals
|